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Abstract
Background: High-throughput sequencing is now regularly used for studies of the transcriptome (RNA-seq),
particularly for comparisons among experimental conditions. For the time being, a limited number of biological
replicates are typically considered in such experiments, leading to low detection power for differential expression. As
their cost continues to decrease, it is likely that additional follow-up studies will be conducted to re-address the same
biological question.
Results: We demonstrate how p-value combination techniques previously used for microarray meta-analyses can be
used for the differential analysis of RNA-seq data from multiple related studies. These techniques are compared to a
negative binomial generalized linear model (GLM) including a fixed study effect on simulated data and real data on
human melanoma cell lines. The GLM with fixed study effect performed well for low inter-study variation and small
numbers of studies, but was outperformed by the meta-analysis methods for moderate to large inter-study variability
and larger numbers of studies.
Conclusions: The p-value combination techniques illustrated here are a valuable tool to perform differential
meta-analyses of RNA-seq data by appropriately accounting for biological and technical variability within studies as
well as additional study-specific effects. An R package metaRNASeq is available on the CRAN
(http://cran.r-project.org/web/packages/metaRNASeq).
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Background
Studies of gene expression have increasingly come to
rely on the use of high-throughput sequencing (HTS)
techniques to directly sequence libraries of reads (i.e.,
nucleotide sequences) arising from the transcriptome
(RNA-seq), yielding counts of the number of reads aris-
ing from each gene. Due to the cost of HTS experiments,
for the time being RNA-seq experiments are typically
performed on very few biological replicates, and there-
fore analyses to detect differential expression between
two experimental conditions tend to lack detection power.
However, as costs continue to decrease, it is likely that
additional follow-up experiments will be conducted to
re-address some biological questions, suggesting a future
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need for methods able to jointly analyze data from mul-
tiple studies. In particular, such methods must be able
to appropriately account for the biological and technical
variability among samples within a given study as well as
for the additional variability due to study-specific effects.
Such inter-study variability may arise due to technical dif-
ferences among studies (e.g., sample preparation, library
protocols, batch effects) as well as additional biological
variability.
In recent years, several methods have been proposed to
analyze microarray data arising from multiple indepen-
dent but related studies; these meta-analysis techniques
have the advantage of increasing the available sample
size by integrating related datasets, subsequently increas-
ing the power to detect differential expression. Such
meta-analyses include, for example, methods to combine
p-values [1], estimate and combine effect sizes [2], and
rank genes within each study [3]; Hu et al. [4] and Hong
and Breitling [5] provide a review and comparison of such
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methods, and Tseng et al. [6] present a recent litera-
ture review and discussion of statistical considerations for
microarray meta-analysis. In particular, Marot et al. [1]
showed that the inverse normal p-value combination tech-
nique outperformed effect size combination methods or
moderated t-tests [7] obtained from a linear model with a
fixed study effect on several criteria, including sensitivity,
area under the Receiver Operating Characteristic (ROC)
curve, and gene ranking.
In many cases the meta-analysis techniques previ-
ously used for microarray data are not directly applicable
for RNA-seq data. In particular, differential analyses
of microarray data, whether for one or multiple stud-
ies, typically make use of a standard or moderated t-
test [7,8], as such data are continuous and may be
roughly approximated by a Gaussian distribution after
log-transformation. On the other hand, the growing body
of work concerning the differential analysis of RNA-
seq data has primarily focused on the use of overdis-
persed Poisson [9] or negative binomial models [10,11]
in order to account for their highly heterogeneous
and discrete nature. Under these models, the calcula-
tion and interpretation of effect sizes is not straight-
forward. Kulinskaya et al. [12] recently proposed an
effect size combination method for Poisson-distributed
data, based on an Anscombe transformation, but this
method is not well-adapted to RNA-seq data due to
the presence of over-dispersion among biological repli-
cates as well as zero-inflation. To our knowledge, no
other transformation has been proposed to obtain effect
sizes for over-dispersed Poisson or negative binomial
data.
In this paper, we consider several methods for the inte-
grated analysis of RNA-seq data arising from multiple
related studies, including two p-value combination meth-
ods as well as a model fitted over the full data with a
fixed study effect. We first demonstrate how the inverse
normal and Fisher p-value combination methods can be
adapted to the differential meta-analysis of RNA-seq data.
Then we compare these two methods to the results of
independent per-study analyses and a negative binomial
generalized linear model (GLM) with a fixed study effect
as implemented in the DESeq Bioconductor package [10].
All methods are compared on real data from two related
studies on human melanoma cell lines, as well as in an
extensive set of simulations varying the inter-study vari-
ability, number of studies, and biological replicates per
study.
Finally, we note that our focus is on RNA-seq data aris-
ing from two or more studies in which all experimental
conditions under consideration are included in every
study (with potentially different numbers of biological
replicates); differential analyses among conditions that
are not studied in the same experiment are typically
limited, or even compromised, due to the confounding of
condition and study effects.
Methods
Let ygcrs be the observed count for gene g (g = 1, . . . ,G),
condition c (c = 1, 2), biological replicate r (r = 1, . . .Rcs),
and study s (s = 1, . . . , S). Note that the number of bio-
logical replicates Rcs may vary between conditions and
among studies. We use dot notation to indicate summa-
tions in various directions, e.g., ygc·s = ∑r ygcrs, yg··s =∑
c
∑
r ygcrs, and so on. Let μgcs be the mean expression
level for gene g in condition c and study s. For an inte-
grated differential analysis of gene expression across all
studies, two approaches can be envisaged: the combina-
tion of p-values from per-study differential analyses, and
a global differential analysis. We illustrate both using the
default methods and parameters of the DESeq (v1.10.1)
analysis pipeline [10], although other popular methods,
e.g., edgeR [11], could also be used; we note that the
recent extensive comparison of Soneson and Delorenzi
[13] provides a helpful guide to choosing an appropriate
method and software package to use in practice.
P-value combination from independent analyses
For the differential analysis of gene expression within a
given study s, we assume that gene counts ygcrs follow a
negative binomial distribution parameterized by its mean
ηgcrs = crsμgcs and dispersion φgs, where crs is a normal-
ization factor to correct for differences in library size. A
comparison of different methods to estimate crs may be
found in Dillies et al. [14].
After obtaining per-gene mean and dispersion param-
eter estimates in each study independently, a parametric
gamma regression is used to obtain fitted dispersion esti-
mates by pooling information from genes with similar
expression strengths. Subsequently, for each gene in each
study, the null hypothesis to be tested is that there is
no difference in the relative proportion of read counts
attributed to each condition, or in other words, that the
gene is non-differentially expressed. Per-gene and per-
study p-values pgs are computed using a conditioned test
analogous to Fisher’s exact test, where the p-value of a
pair of observed count sums (yg1·s, yg2·s) is calculated as












where it is assumed that p(a, b) = p(a)p(b), and p(a) and
p(b) represent the probability of a and b counts in the first
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and second conditions, respectively. These probabilities
are calculated using the negative binomial distributions
parameterized by the corresponding estimated mean and
dispersion parameters, μgcs and φgs.
Additional details are described by Anders and Huber
[10] and in the DESeq package vignette. Once these vec-
tors of raw p-values have been obtained for each study, we
consider two possible approaches to combine them: the
inverse normal and the Fisher combination methods. We
note that both of these approaches assume that under the
null hypothesis, each vector of p-values is assumed to be
uniformly distributed.
Inverse normalmethod




ws−1(1 − pgs) (1)
where pgs corresponds to the raw p-value obtained for
gene g in a differential analysis for study s,  the cumu-
lative distribution function of the standard normal distri-
bution, and ws a set of weights [15,16]. We propose here
to define the study-specific weights ws, as described by










c Rcs is the total number of biological replicates in
study s. This allows studies with large numbers of biologi-
cal replicates to be attributed a larger weight than smaller
studies. We note that other weights may also be defined
by the user depending on the quality of the data in each
study, if this information is available.
Under the null hypothesis, the test statistic Ng in
Equation (1) follows a N (0, 1) distribution. A unilateral
test on the right-hand tail of the distribution may then
be performed, and classical procedures for the correc-
tion of multiple testing such as the approach of Benjamini
and Hochberg [18] may subsequently be applied to the
obtained p-values to control the false discovery rate at a
desired level α.
Fisher combinationmethod
For the Fisher combination method [19], the test statistic









where as before pgs corresponds to the raw p-value
obtained for gene g in a differential analysis for study
s. Under the null hypothesis, the test statistic Fg in
Equation (2) follows a χ2 distribution with 2S degrees of
freedom. As with the inverse normal p-value combination
method, classical procedures for the correction of multi-
ple testing [18] may be applied to the obtained p-values to
control the false discovery rate at a desired level α.
Additional considerations for p-value combination
We note that the implementation of the previously
described p-value combination techniques requires two
additional considerations to be taken into account when
dealing with RNA-seq data.
First, a crucial underlying assumption for the statis-
tics defined in Equations (1) and (2) is that p-values for
all genes arising from the per-study differential analyses
are uniformly distributed under the null hypothesis. This
assumption is, however, not always satisfied for RNA-seq
data; in particular, a peak is often observed for p-values
close to 1 due to the discretization of p-values for very low
counts. To circumvent this first difficulty, as is commonly
done for differential analyses in practice, we propose to
filter the weakly expressed genes in each study, using the
HTSFilter Bioconductor package [20] as described in
the Additional file 1. We note that in so doing, it is possi-
ble for a gene to be filtered from one study and not from
another. As will be seen in the following, this approach
appears to effectively filter those genes contributing to
a peak of large p-values, resulting in p-values that are
roughly uniformly distributed under the null hypothesis.
Second, for the two p-value combination methods
described above, unlike microarray data, under- and over-
expressed genes are analyzed together for RNA-seq data.
As such, some care must be taken to identify genes
exhibiting conflicting expression patterns (i.e., under-
expression when comparing one condition to another in
one study, and over-expression for the same comparison
in another study). In the case of microarray data, Marot
et al. [1] suggested the use of one-tailed p-values for each
study to avoid directional conflicts; as the inverse normal
combination method was used in their work, the com-
bined statistic thus follows a normal distribution, which is
symmetric. Because under- and over-expressed genes may
be found in the left and right tail, respectively, of the cor-
responding normal distribution, it is thus possible to use
a two-tailed test to simultaneously study over and under-
expressed genes. Note that Pearson [21] and Owen [22]
proposed another alternative to handle conflicting differ-
ential expression if the Fisher combinationmethod is used
instead. However, in the case of RNA-seq data, the use of
the conditioned test described above does not enable the
separation of over- and under-expressed genes in distri-
bution tails; this implies that it is not possible to use the
approaches proposed by Marot et al. [1] or Owen [22].
We thus suggest that genes exhibiting differential expres-
sion conflicts among studies be identified post hoc, and
removed from the list of differentially expressed genes;
this step to remove genes with conflicting differential
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expression from the final list of differentially expressed
genes may be performed automatically within the associ-
ated R package metaRNASeq.
Global differential analysis
For a global analysis of RNA-seq data arising from mul-
tiple studies, we assume that gene counts ygcrs follow a
negative binomial distribution parameterized by mean
ηgcrs = crsμgcs and dispersion φg , where crs is the library
size normalization factor. In order to estimate a possible
effect due to study, a full and reduced model are fitted
for each gene using negative binomial generalized linear
models (GLM); the full model regresses gene expression
on fixed effects for the experimental condition and study,
while the reduced model regresses gene expression only
on a fixed effect for the study.
Specifically, the full model is log
(
ηgcrs
) = βg + λgc +
δgs + log(crs), where βg is an intercept, λgc is a fixed condi-
tion effect, δgs a fixed study effect, and λg1 = δg1 = 0, with
the choice of the condition and study to be used as refer-




βg+δgs+log(crs). Per-gene dispersion parameters are esti-
mated as before, where a parametric gamma regression
is used to obtain fitted dispersion estimates by pooling
information from genes with similar expression strengths
across all studies.
We are now interested in testing the global per-gene null
hypothesis
H0,g : ∀c, λgc = 0 vs H1,g : ∃c | λgc = 0.
Following parameter estimation, the two models are
compared using a χ2 likelihood ratio test (with degrees
of freedom equal to the number of conditions minus one)
to determine whether including the experimental condi-
tion significantly improves the model fit. Note that for
the global differential analysis we use the HTSFilter
Bioconductor package [20] to filter the full set of data
across studies prior to calculating p-values, resulting in a
single vector of raw filtered per-gene p-values that may be
corrected for multiple testing using classical procedures
[18] to control the false discovery rate at a desired level
α. Additional details may be found in the DESeq package
vignette.
Results and discussion
Application to real data
Presentation of the data
The negative binomial GLM and p-value combination
methods were applied to a pair of real RNA-seq studies
performed to compare two human melanoma cell lines
[23]. Each study compares gene expression in a melanoma
cell line expressing the Microphtalmia Transcription Fac-
tor (MiTF) to one in which small interfering RNAs
(siRNAs) were used to repress MiTF, with three biological
replicates per cell line in the first (hereafter referred to as
Study A) and two per cell line in the second (Study B).
The raw read counts and phenotype tables for Study A are
available in the Supplementary Materials of Dillies et al.
[14], and the data from Study B from Strub et al. [23].
The characteristics of the data from these two studies
are summarized in Additional file 1: Table S1. In partic-
ular, we note that the data from Study A tend to have
larger total library sizes and a smaller number of unique
reads (i.e. reads that appear once in the reference genome)
than those from Study B; in addition, Study A appears to
exhibit larger overall per-gene variability than does Study
B (Additional file 1: Figure S8). These two points indicate
that in this pair of studies, a considerable amount of inter-
study heterogeneity appears to be present (Additional
file 1: Figure S9).
Results
After performing individual differential analysis for each
study using the negative binomial model and exact test
as described in the previous section, we obtained per-
gene p-values for each study (Figure 1, histograms in
background). As previously stated, an important under-
lying assumption of the p-value combination methods
is that the p-values are uniformly distributed under the
null hypothesis; we note that this is not the case here,
especially for the second study, due to a large peak of
values close to 1 resulting from the discretization of p-
values. In order to remove the weakly expressed genes
contributing to this peak in each study, we filtered the
data from each study as proposed in Rau et al. [20], result-
ing in a distribution of raw p-values from each study that
appears to satisfy the uniformity assumption under the
null hypothesis (Figure 1, histograms in foreground).
The per-study filtered p-values were combined using
the test statistics defined in Equations (1) and (2), and
the corresponding results were compared to those of the
intersection of independent per-study analyses and the
global analysis using a negative binomial GLM with a
fixed study effect as previously described.We note that for
the independent per-study differential analyses, a gene is
declared to be differentially expressed if identified in both
studies with no differential expression conflict. For the
Inverse normal and Fisher methods, a total of 310 (6.8%
of differentially expressed genes) and 439 (9.0% of differ-
entially expressed genes) genes were respectively found
to exhibit conflicting expression between the two stud-
ies, and were subsequently removed from the final list of
differentially expressed genes. Unsurprisingly, these genes
tended to be those with relatively large p-values in both
studies (Additional file 1: Figure S11).
In addition, we also investigated whether genes
identified as differentially expressed by the Inverse nor-
mal and Fisher methods tended to be disproportionately
























Figure 1 Raw p-value histograms from per-study differential analyses of real data. Histograms of raw p-values obtained from per-study
differential analyses in the real data from Study A (left) and Study B (right): unfiltered (in grey) and filtered (in blue) using the method of [20].
Figure made using the ggplot2 package [24].
dominated by one study over the other, i.e. very small
p-values in only one study (Additional file 1: Figure S12).
Although Study B appears to have slightlymore genes with
very small p-values, for the most part, p-values for differ-
entially expressed genes tend to be well-balanced between
the two studies.
The Venn diagram presented in Figure 2 compares the
lists of differentially expressed genes found for all methods
considered. It may immediately be noticed that the inde-
pendent per-study analysis approach is very conservative,
and both of the p-value combination approaches (Fisher
and inverse normal) considerably increase the detection
power. In addition, a large number of genes are found in
common among the p-value combination methods and
the global analysis (3578 compared to only 1583 from
the intersection of individual studies). In order to deter-
mine whether the genes uniquely identified by a particular
method appear to be biologically pertinent, an Ingenuity
Pathways Analysis (Ingenuity® Systems, www.ingenuity.
com) was performed to identify functional annotation
for the genes uniquely identified by the Fisher p-value
combination method with respect to the global analysis,
and vice versa. We note that the sets of genes uniquely
identified by the Fisher method or the global analysis
(Additional file 1: Tables S2 and S3), as well as the set
of genes found in common (Additional file 1: Table S4),
all appear to include genes of potential interest related
to cancer or melanoma, which was the main focus of
this set of studies. As such, for this pair of studies it
appears that the union of genes identified by the two
approaches may be of biological interest; to further study
the effect of number of studies and inter-study vari-
ability on the performance of each method, we investi-
gate an extensive set of simulated data in the following
section.
Simulation study






where μgcs and φgs represent the mean and dispersion,
respectively, for gene g, condition c and study s, and the




) = μgcs + μ2gcs
φgs
.
In order to incorporate inter-study variability, we con-




) = θgc + εgcs, and εgcs ∼ N (0, σ 2) ,
where θgc represents the mean for gene g in condition c,
εgcs the variability around these means due to a study-
and condition-specific random effect, and σ 2 the size of
the inter-study variability. Note that as εgcs affects μgcs





tive effect on the mean.
Parameters for simulations





first performed individual per-study differential analy-
ses by fitting a negative binomial model with the default
methods and parameters of the DESeq package on the
unfiltered human data presented above. The per-study
false discovery rate was subsequently controlled at the
α = 0.05 level [18]. For the genes identified as differen-
tially expressed in both studies, θg1 and θg2 were fixed to
be the values of the empirical means (after normalization
for library size differences) for each condition across stud-
ies. For the remaining genes, we set θg1 = θg2 = θg to be
the overall empirical mean (after normalization for library
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Figure 2 Comparison of results from differential analyses of real data. Venn diagram presenting the results of the differential analysis for the
real data for the two meta-analysis methods (Fisher and inverse normal), the global analysis (DESeq (study)), and the intersection of individual
per-study analyses (Individual). Figure made using the VennDiagram package [25].
size differences) for gene g across both conditions and
studies. Using the gamma-family GLM fitted to the per-
gene mean and dispersion parameter estimates for each
study (Additional file 1: Figure S8), we fixed the dispersion
parameter φgs to be equal to the fitted values




where γˆ0s and γˆ1s are the estimated coefficients from
the gamma-family GLM for study s, and θg is the overall
empirical mean for gene g. For weakly expressed genes,
it has been observed that little overdispersion is present
as biological variation is dominated by shot noise (i.e.,
the variation inherent to a counting process); for genes
with θg < 10, the dispersion parameter is therefore fixed
to be φgs = 1010, which corresponds to nearly zero
overdispersion (i.e., mean nearly equal to the variance).
Finally, the parameter σ is chosen to represent a range
of values for the amount of inter-study variability. The
observed human data exhibit a considerable amount of
inter-study variability, corresponding to a value of roughly
σ = 0.5 (see Additional file 1: Figure S9). In the following
simulations, four values are considered for the parame-
ter σ : {0, 0.15, 0.3, 0.5}, representing zero, small, medium,
and large inter-study variability, respectively. Finally, we
note that for genes simulated to be non-differentially
expressed, we set εg1s = εg2s = εgs ∼ N (0, σ 2).
The simulation settings used for the number of stud-
ies and number of replicates per condition in each study
are presented in Table 1 and were chosen to reflect the
size of real RNA-seq experiments. When more than two
studies were simulated, the same simulation parameters
were used as for the first two, as determined from the real
data. For simplicity, the same number of replicates was
simulated in each condition for all studies.
Methods and criteria for comparison
In addition to the intersection of independent per-study
analyses (where genes were declared to be differentially
expressed if identified inmore than half of the studies with
no differential conflict), the Fisher and inverse normal
p-value combination techniques, and the global analysis
with fixed study effect, we also considered a global anal-
ysis with no study effect. For each simulation setting and
level of inter-study variability σ , 300 independent datasets
were simulated, and the filtering method of Rau et al.
[20] was applied, either independently to each study (for
the independent per-study analyses and p-value combina-
tion techniques) or to the full set of data (for the global
analysis).
For each method, performance was assessed using the
sensitivity, false discovery rate (FDR) and area under the
receiver operating characteristic (ROC) curve (AUC). In
addition, we also considered a criterion to assess the
“value added” for the p-value combination methods with
Table 1 Parameter settings for the simulations, including
the number of studies and the number of replicates per
condition in each study




Parameter settings for the simulations, including the number of studies and the
number of replicates per condition in each study.
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respect to the global analysis, and vice versa: the propor-
tion of true positives among those uniquely identified by
a given method (e.g., the Fisher approach) as compared to
another (e.g., the global analysis).
Results
The different methods were first compared with ROC
curves, presented in Figure 3 for low and high inter-study
variability (results for zero and moderate inter-study vari-
ability are shown in Additional file 1: Figure S5). We note
that for clarity, the inverse normal method is not repre-
sented on these plots as its performance was found to
be equivalent to the Fisher method. It can first be noted
that for no or small inter-study variability (σ = 0 or
σ = 0.15), no practical difference may be observed among
the methods. On the other hand, for moderate to large
inter-study variability (σ = 0.3 or σ = 0.5) differences
among the methods become more apparent; this pat-
tern is observed for any number of studies. As expected,
including a study effect in the global analysis improves
the performance over a naive global analysis without such
an effect. We note that the two proposed meta-analysis
methods (inverse normal and Fisher p-value combination)
were found to perform very similarly and were able, in
the case of large inter-study variability, to outperform
the global analysis in terms of AUC (Additional file 1:
Figure S1). In particular, in the presence of large inter-
study variability, the naive global analysis without a study
effect unsurprisingly has the lowest AUC, and the two
meta-analysis methods yield a larger AUC than the global
analysis with a study effect.
Considering the sensitivity (Figure 4 and Additional
file 1: Figure S6), the meta-analyses appear to lead to sim-
ilar, and in some settings considerably higher, detection
power compared to the other methods. We note that in
all settings, using the intersection of independent analy-
ses leads to much lower sensitivity, even for low or zero
inter-study variability. As for the AUC, the sensitivity was
found to be considerably improved for the global analysis
when including a study effect in the GLM model, partic-
ularly for medium to large inter-study variability. The two
meta-analysis methods were found to lead to significant
improvements in sensitivity as compared to the global
analysis in the presence of moderate to large inter-study
variability when three or more studies were considered.
However, for the setting that most resembles our real



































































































Figure 3 Receiver operating characteristic curves for low and high inter-study variability. Receiver Operating Characteristic (ROC) curves,
averaged over 300 datasets. Each plot represents the results of a particular setting, with columns corresponding (from left to right) to simulations
including 2 studies, 3 studies, and 5 studies, and rows corresponding (from top to bottom) to simulations with inter-study variability set to σ = 0.15
and σ = 0.50 (small to large inter-study variability). Within each plot: Fisher (red lines), global analysis with no fixed study effect (DESeq (no study),
blue lines), and global analysis with a fixed study effect (DESeq (study), orange lines). The dotted black line represents the diagonal.



















































































Figure 4 Sensitivity for low and high inter-study variability. Sensitivity, for the simulation settings corresponding to σ = 0.15 and σ = 0.50.
Each barplot represents the results of a particular setting, with columns corresponding (from left to right) to simulations including 2 studies, 3
studies, and 5 studies, and rows corresponding (from top to bottom) to simulations with inter-study variability set to σ = 0.15 and σ = 0.50 (low
inter-study variability to large inter-study variability). Within each barplot, from left to right: Individual per-study analyses (green bars), inverse normal
(purple bars), Fisher (red bars), global DESeq with no study effect (blue bars), and global DESeq with a fixed study effect (orange bars).
data analysis (2 studies, σ = 0.50), the global analysis
with study effect andmeta-analyses appear to have similar
detection power. Finally, we also note that for all methods
the FDR was well controlled below 5% (Additional file 1:
Figure S2).
Based on these criteria, the two proposed meta-analysis
methods (inverse normal and Fisher) seem to perform
very similarly. In order to more thoroughly investigate the
differences between p-value combination methods and
the global analysis including a study effect, we calculated
the proportion of true positives uniquely detected by the
Fisher method as compared to the global analysis with
study effect, and vice versa (Figure 5 and Additional file 1:
Figure S7). In the setting closest to the real data analysis
presented above (two studies and large inter-study vari-
ability), the proportion of true positives found uniquely by
either the Fisher approach or the global analysis with fixed
study effect are very large (around 80% for both methods).
This seems to suggest that the additional genes uniquely
found either by the global analysis or Fisher p-value com-
bination method in the real data application may indeed
be of great biological interest. For more than two stud-
ies, however, as the inter-study variability increases the
proportion of truly differentially expressed genes uniquely
found by the Fisher method increases compared to the
global analysis. For example, for three studies with large
inter-study variability (σ = 0.5), the proportion of truly
DE genes uniquely found with the Fisher method was
equal to more than 80%, whereas it was only around 40%
for the global analysis with a study effect.
Conclusions
The aim of this paper was to present and compare
different strategies for the differential meta-analysis of
RNA-seq data arising from multiple, related studies. As
expected, naive analyses such as the overlap of lists of dif-
ferentially expressed genes found by individual studies or
a global analysis not accounting for a study effect perform
very poorly. On the other hand, the two proposed meta-
analysis methods seem to have very similar performances.
For low inter-study variability, the results are very close to
those of a global GLM analysis including a study effect.
When the inter-study variability increases, however, the
gains in performance in terms of AUC, sensitivity, and
proportion of true positives among uniquely identified
genes for the meta-analysis techniques are significant as
compared to the global analysis, particularly for the analy-
sis of data from more than two studies. We note that both
of the proposed p-value combination methods are imple-
mented in an R package called metaRNASeq, available
on the CRAN; a package vignette describing the use of
metaRNASeq may be found in Additional file 2 as well
as by calling vignette("metaRNASeq") after loading
the package in R.
Our focus in this work is on differential analyses
between two experimental conditions, but can readily be
















































































Figure 5 Proportion of true positives among unique discoveries. Proportion of true positives among unique discoveries for DESeq with a fixed
study effect (orange bars) and Fisher (red bars). Each barplot represents the results of a particular setting, with columns corresponding (from left to
right) to simulations including 2 studies, 3 studies, and 5 studies, and rows corresponding (from top to bottom) to simulations with inter-study
variability set to σ = 0.15 and σ = 0.50 (low inter-study variability to large inter-study variability). Error bars represent one standard deviation, and
numbers in parentheses represent the mean total number of unique discoveries for DESeq with study effect as compared to Fisher and vice versa,
respectively.
extended to multi-group comparisons. However, as pre-
viously noted, the methods presented here are intended
for the analysis of data in which all experimental condi-
tions under consideration are included in every study, thus
avoiding problems due to the confounding of condition
and study effects. As with all meta-analyses, the p-value
combination techniques presented here must overcome
differences in experimental objectives, design, and pop-
ulations of interest, as well as differences in sequencing
technology, library preparation, and laboratory-specific
effects.
The differential meta-analyses presented here concern
expression studies based on RNA-seq data. However,
other genomic data are generated by high-throughput
sequencing techniques, including chromatin immunopre-
cipitation sequencing (CHIP-seq) and DNA methylation
sequencing (methyl-seq), and the proposed techniques
could potentially be extended to these other kinds of data.
However, in order to be biologically relevant, the p-value
combination methods rely on the fact that the same test
statistics, or in the case of RNA-seq data conditioned
tests, are used to obtain p-values for each study. An impor-
tant challenge for the future will be to propose methods
able to jointly analyze related heterogeneous data, such as
microarray and RNA-seq data, or other kinds of genomic
data. This is not straightforward in a meta-analysis frame-
work and remains an open research question.
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discussion concerning the filtering of RNA-seq data, supplementary
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Additional file 2: metaRNASeq vignette. This document contains a
vignette describing in greater detail the metaRNASeq R package. It can
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